Vutham Vilasini Soukya, Ginnela Sabitha


The hypoxic conditions in the brain of Central nervous system may lead to the death of the tissues. This process is a
form of autolysis that is programmed due to the effect of cells in the brain. It occurs mostly due to trauma,
hypertension, diabetes mellitus, or arteriovenous malformation. In this condition the patient may have severe facial drooling, weakness,
headache, seizures and loss of balance, speech disturbance, nausea and vomiting.
A prospective observational study was carried out in a tertiary care hospital to evaluate tissue necrosis in hemorrhagic stroke patients with
treatment regimen and therapeutic outcomes by the medication.
Sampling method: All the patients of age above 36-70 years suffering with stroke were included in the study.
Study site: The study was conducted in an intensive care unit of 500 bedded tertiary care hospital.
Study procedure: The study was done by collecting data by using patient case sheets, based on that data a questionnaire was prepared
according to the guidelines of WHO and HRQOL. Nearly a data of 72 patients were included in the study with all the details of past medical
history, the treatment regimen and laboratory parameters with frequency were collected.
Study duration: The duration of the study was 12 months (August 2017 to August 2018).
RESULTS: Out of 90 patients, 72 patients cooperated with us and provided the information that was the treatment regimen of stroke,
reasons for admission and the results were discussed.
DISCUSSION: Out of 72 patients in our study who were suffering with hemiplegia the age group of 35- 70 years in which 50-60years was
higher (33.33%). The reasons for the admission of patients were trauma (19.44%), hypertension (15.27), diabetes mellitus (13.88%) and the
co morbidity for the hospitalization was hypertension (51.38%) and diabetes mellitus (34.72%). The treatment regimen for the stroke and
general symptoms are mainly antibiotics, anti platelets, multivitamins.
CONCLUSION: Our study concludes that most of the patients were admitted in the hospital due to trauma and complication of diabetes. So
there is a great need of adoption of various strategies to prevent trauma conditions and complications. As clinical pharmacists, if we counsel
the public regarding their health and lifestyle modi􀃶cations we can reduce the chances of stroke and we also should provide the
information regarding hypertension, diabetes and complications of stroke. The awareness programmes conducted by the government
may also reduce the cases of stroke.


Hypoxia, Hemorrhagic stroke, Hypertension, Diabetes mellitus

Full Text:



Joseph T Dipiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael posey, “Pharmacotherapy – A Pathophysiologic Approach” , McGraw Hill; 7 ; 375-382

Roger walker, Cate Whittlesea, “Clinical pharmacy and Therapeutics”, Churchill Livingston ; fifth edition 5 ;

Laurence L. Brunton, Bruce A. Chabner, Björn C. Knollmann,“ Goodman & Gilman's - The Pharmacological Basis of Therapeutics”, 12thedition

https://www.ncbi.nim.nih.gov/pmc/articles/pmc 3388250


http://www.stroke.org/hemorrhagic stroke

http://www.strokeassociation.org/STROKEORG/AboutStroke/Typesofstroke/Hemorrhagic bleeds/Hemorrhagic-Strokes-Bleeds_UCM_310940_Article.jsp#main content


Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J. Early hemorrhage growth in patients with intracerebralhemorrhage. Stroke. 1997; 28: 1–5

Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O. Hematoma enlargement in spontaneous intracerebralhemorrhage. J Neurosurg. 1994; 80: 51–57.

Batjer HH, Reisch JS, Allen BC, Plaizier LJ, Su CJ. Failure of surgery to improve outcome in hypertensive putaminalhemorrhage. A prospective randomized trial. Arch Neurol. 1990; 47: 1103–1110.

hiex R, Kuker W, Muller HD, Rohde I, Schroder JM, Gilsbach JM, Rohde V. The long- term effect of recombinant tissue-plasminogen-activator (rt-PA) on edema formation in a large-animal model of intracerebralhemorrhage. Neurol Res. 2003; 25: 254–262.

Auer LM, Auer T, Sayama I. Indications for surgical treatment of cerebellar haemorrhage and infarction. ActaNeurochir (Wien). 1986; 79: 74–79.

Kirollos RW, Tyagi AK, Ross SA, van Hille PT, Marks PV. Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery. 2001; 49: 1378–1386.

Schellinger PD, Fiebach JB, Hoffmann K, Becker K, Orakcioglu B, Kollmar R, Juttler E, Schramm P, Schwab S, Sartor K, Hacke W. Stroke MRI in intracerebralhemorrhage: is there a perihemorrhagic penumbra? Stroke. 2003; 34: 1674–1679.

Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorialintracerebralhemorrhage. Stroke. 1998; 29: 1352–1357.

Vespa PM, O’Phelan K, Shah M, Mirabelli J, Starkman S, Kidwell C, Saver J, Nuwer MR, JG, McArthur DA, Martin NA. Acute seizures after intracerebralhemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003; 60: 1441–1446

Gebel JM, Brott TG, Sila CA, et al. Decreased perihematomaledema in thrombolysis-related intracerebralhemorrhage compared with spontaneous intracerebralhemorrhage. Stroke. 2000; 31:596–600.


  • There are currently no refbacks.